DIAMORPHINE HYDROCHLORIDE BP 5MG LYOPHILISATE FOR SOLUTION FOR INJECTION

Active substance: DIAMORPHINE HYDROCHLORIDE

View full screen / Print PDF » Download PDF ⇩

Transcript
PATIENT INFORMATION LEAFLET
Diamorphine Hydrochloride BP for Injection 5 mg, 10 mg and 30 mg
Lyophilisate for Solution for Injection
Read all of this leaflet carefully,
before you are given this injection.
• Keep this leaflet. You may need to
read it again.
• If you have any other questions,
please ask your doctor.
• If any of the side effects gets
serious, or if you notice any side
effects not listed in this leaflet,
please tell your doctor.
Before being used, the powder in the
ampoules will be mixed with a
liquid to make a solution which will
be given to you by injection. This is
called Diamorphine Hydrochloride
BP Injection in this leaflet.

1. What Diamorphine
Hydrochloride BP Injection is
and what it is used for
2. Before you are given the
injection
3. How the injection is given
4. Possible side effects
5. Storing the injection
6. Further information
1. WHAT DIAMORPHINE
HYDROCHLORIDE BP
INJECTION IS AND WHAT IT IS
USED FOR
Diamorphine hydrochloride belongs
to a class of medicines known as
opioid analgesics. They help to
relieve pain.
Diamorphine Hydrochloride BP
Injection can be used to
• relieve severe pain associated
with surgery, a heart attack or a
terminal illness, or
• relieve breathlessness caused by
fluid in the lungs.

• you have severe problems with
breathing or suffer from bronchitis
or asthma

ViroPharma
Job No.:

3008621301

Black

Cutterguide

• you have raised pressure in your
brain
• you have recently been treated for
depression with drugs called
mono amine oxidase inhibitors
(MAOIs)
• you are pregnant or
breast-feeding.
Before having the injection make
sure your doctor is aware if:
• you are ill or elderly
• you have problems with your liver
or kidneys
• you have a head injury
• you are an alcoholic or have a
history of drug abuse
• you have a mental illness
• you have problems with your
thyroid, adrenal glands, prostate,
bladder or bowel
• you have diarrhoea
• you have a severely deformed
spine.

100% 95%

50%

5%

Product Name

Diamorphine
Hydrochloride BP
5mg / 10mg / 30mg

Market
Component
No. of Colours
Profile
Dimensions
Point of Sale Code
Pharmacode
Production Site No.
Packaging
Supplier
Originated on
Originated by
Originated at

UK
Leaflet
1 (One)
N/A
296 x 129 mm
N/A

F491 / B492
3008621301
IDT
22/03/2013
Operator 006
ARK

Proof Status
P4 / M4
Amended by
Operator 004
Date Completed 23/05/2013
TEXT SIZES
Main Body Text
Line Spacing

8.55pt
11pt

FONTS USED

Helvetica

Are you taking other medicines?
Before the doctor gives you the
injection tell him/her if you are
taking any of the following
medicines:
• Drugs to treat depression or mental
illness including phenothiazines or
tricyclic antidepressants as well as
monoamine oxidase inhibitors

• Tranquillisers or sleeping tablets
• Antimuscarinic drugs such as
atropine
• Drugs to prevent vomiting such as
metoclopramide or domperidone

2. BEFORE DIAMORPHINE
HYDROCHLORIDE BP
INJECTION IS GIVEN TO YOU

• Cisapride which is used to
stimulate the gut

Diamorphine Hydrochloride BP
Injection is not suitable for
everyone. Tell the doctor or nurse
that you must not have the
injection if:

Artwork Approval Signature Box
Ark
Proofreader

Site Packaging

Viropharma
Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
Tel +44(0)1322 424656

• An antibiotic called a 4-quinolone

• you are aware that you are allergic
to diamorphine or any other opioid
analgesic such as codeine
• you have a tumour of the adrenal
gland near your kidney

• Selegiline, a drug used in
Parkinson’s disease
• Cimetidine, used to treat stomach
ulcers and indigestion, or if

PHARMA GRAPHICS

ViroPharma Version 2 - August 2012

PAGE 1 of 2

• You have been drinking alcohol.
Make sure you tell your doctor
about any other medicines you
are taking or have taken recently,
including any bought from a
chemist or another shop.

OFF-PACK PHARMACODE
Number: 491

First Bar

Pregnancy and childbirth
• If you are given diamorphine
during pregnancy, there is a risk
that your baby might become
dependant on it and suffer from
withdrawal symptoms after birth.
• If you are given diamorphine
during labour there is a risk that
you could be sick and have
breathing difficulties, or the baby
could have difficulty starting to
breathe.
Driving and using machines
The injection may cause drowsiness
and loss of concentration so you
should not operate a machine or
drive a vehicle.
3. HOW THE INJECTION IS GIVEN

The doctor will prepare the
injection by mixing the powder
with a liquid. He/she will know
how much to give you. You can
have the injection either under the
skin, or into a muscle, or directly
into a vein (called intravenous
infusion).
The usual doses for adults are:
To relieve pain 5 – 10 mg every 4
hours injected under the skin or into a
muscle.
If the drug is given directly into a
vein, you will be given one quarter or
one half of this dose.

passing water, spasm of the bile duct,
feeling faint on standing up, facial
flushing, palpitations, mood changes,
dry mouth, skin rash, itching and
headache.

ViroPharma
Job No.:

3008621301

Black

Cutterguide

If you have the injections for a long
time you might become dependent on
the drug and have withdrawal
symptoms if it is suddently stopped.
100% 95%

If you experience any other
side-effects or feel that the medicine
is affecting you badly, tell your doctor
or nurse immediately.

50%

5%

Product Name

Diamorphine
Hydrochloride BP
5mg / 10mg / 30mg
UK

• Diamorphine Hydrochloride BP
Injection must be used mmediately
after the solution has been
prepared.

Market
Component
No. of Colours
Profile
Dimensions
Point of Sale Code
Pharmacode
Production Site No.
Packaging
Supplier
Originated on
Originated by
Originated at

• Diamorphine Hydrochloride BP
Injection must be kept in a secure
place out of the reach and sight of
children.

Proof Status
P4 / M4
Amended by
Operator 004
Date Completed 23/05/2013

• Diamorphine Hydrochloride BP is
a Controlled Drug and must be
stored and disposed of according
to regulations.

TEXT SIZES
Main Body Text
Line Spacing

8.55pt
11pt

FONTS USED

Helvetica

5. STORING THE INJECTION

• Do not store above 25 °C. Keep
the injection in the outer carton to
protect it from light.
• This medicine should not be used
after the expiry date on the carton
or if the powder in the ampoule or
the solution are discoloured.

The dose may be increased if
necessary.

Each 2 ml ampoule contains either
5 mg, 10 mg or 30 mg of the active
ingredient, Diamorphine
Hydrochloride BP, which is a white or
off-white powder. The medicine is
prepared for use by dissolving the
powder in a liquid.

N/A

F491 / B492
3008621301
IDT
22/03/2013
Operator 006
ARK

6. FURTHER INFORMATION

Following a heart attack 5 mg
directly into a vein, followed, if
needed, by a further 2.5 – 5 mg.

Leaflet
1 (One)
N/A
296 x 129 mm

For fluid in the lungs 2.5 – 5 mg
directly into a vein.

The elderly, children or people
with liver or kidney problems, may
be given a lower starting dose.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Diamorphine
Hydrochloride BP Injection may
cause side effects in a few people.
The most serious side effect is that
your breathing or circulation may
become depressed. Your breathing
may become shallow or you may
collapse.
The most common side effects are
drowsiness, feeling or being sick,
constipation and sweating.
Other side-effects, which may
occur, include dizziness, constricted
pupils (eye), confusion, difficulty in

Each pack contains 5 glass
ampoules.
Marketing Authorisation Holder:
ViroPharma Ltd, Chatsworth House,
29 Broadway, Maidenhead,
SL6 1LY United Kingdom
Email: uk.medinfo@viropharma.com
Manufacturer:
ViroPharma SPRL,
rue Montoyer 47,
Brussels 1000, Belgium

Artwork Approval Signature Box
Ark
Proofreader

Site Packaging

Viropharma
Approval

ARK

PHARMA GRAPHICS

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
Tel +44(0)1322 424656

ViroPharma Version 2 - August 2012

PAGE 2 of 2

This leaflet was prepared in
May 2013.
OFF-PACK PHARMACODE
Number: 492

V491/R492-3008621301
First Bar

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)